Cargando…
PTEN, PTENP1, microRNAs, and ceRNA Networks: Precision Targeting in Cancer Therapeutics
SIMPLE SUMMARY: The PTEN gene is an important and well-characterised tumour suppressor, known to be altered in many cancer types. Interestingly, the effect of the loss or mutation of PTEN is not dichotomous, and small changes in PTEN cellular levels can promote cancer development. Less well-known me...
Autores principales: | Travis, Glena, McGowan, Eileen M., Simpson, Ann M., Marsh, Deborah J., Nassif, Najah T. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10605164/ https://www.ncbi.nlm.nih.gov/pubmed/37894321 http://dx.doi.org/10.3390/cancers15204954 |
Ejemplares similares
-
PTEN/PTENP1: ‘Regulating the regulator of RTK-dependent PI3K/Akt signalling’, new targets for cancer therapy
por: Haddadi, Nahal, et al.
Publicado: (2018) -
PTENP1 is a ceRNA for PTEN: it’s CRISPR clear
por: Vitiello, Marianna, et al.
Publicado: (2020) -
Long non-coding RNA PTENP1 functions as a ceRNA to modulate PTEN level by decoying miR-106b and miR-93 in gastric cancer
por: Zhang, Rupeng, et al.
Publicado: (2017) -
“Dicing and Splicing” Sphingosine Kinase and Relevance to Cancer
por: Haddadi, Nahal, et al.
Publicado: (2017) -
The analysis of novel microRNA mimic sequences in cancer cells reveals lack of specificity in stem-loop RT-qPCR-based microRNA detection
por: Winata, Patrick, et al.
Publicado: (2017)